Actively Recruiting
Comparing Efficacy of Microwave Vs Embolization Treatment for Adenomyosis
Led by Karolinska Institutet · Updated on 2024-11-20
70
Participants Needed
1
Research Sites
301 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Single blinded randomized controlled study of symptom improvement after uterine artery embolization (UAE) versus ultrasound guided percutaneous/transvaginal microwave ablation, evaluated by validated questionnaires. Adenomyosis is a benign condition causing pain and bleeding disorders in many women. Hysterectomy has historically been the golden standard for treatment as well as (postoperatively) diagnosis of the disease. In accordance with refined diagnostic tools such as ultrasound and/or MRI, minimally invasive treatments for adenomyosis are being explored. We plan to compare two minimally invasive techniques: embolization of the uterine artery (a commonly used procedure) and microwave ablation of adenomyotic tissue (previously only in clinical use in China).
CONDITIONS
Official Title
Comparing Efficacy of Microwave Vs Embolization Treatment for Adenomyosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy women aged 30-55 with symptomatic adenomyosis
- Premenopausal
- Adenomyosis diagnosted by TVUS
- Willing to comply with protocol
You will not qualify if you...
- Body Mass Index >35
- Treatment with anticoagulant/bleeding disorder
- Contraindication for UAE or general anesthesia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Danderyd Hospital
Stockholm, Sweden, 182 88
Actively Recruiting
Research Team
K
Klara Hasselrot, MD PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here